🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, alleging the corporations withheld potential risks that the drug created to pediatric brain development.

The court filing arrives four weeks after Former President Trump publicized an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - during pregnancy and autism in offspring.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by profiting off of discomfort and pushing pills ignoring the dangers."

The company states there is lacking scientific proof tying acetaminophen to autism.

"These companies deceived for years, knowingly endangering numerous people to line their pockets," Paxton, from the Republican party, said.

The company stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its website, Kenvue also said it had "consistently assessed the relevant science and there is lacking reliable evidence that demonstrates a proven link between consuming paracetamol and autism spectrum disorder."

Organizations acting on behalf of medical professionals and health professionals share this view.

ACOG has stated acetaminophen - the key substance in acetaminophen - is one of the few options for expectant mothers to manage discomfort and fever, which can pose major wellness concerns if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any trimester of gestation results in brain development issues in children," the organization stated.

This legal action mentions latest statements from the Trump administration in arguing the medication is reportedly hazardous.

Recently, the former president raised alarms from medical authorities when he told expectant mothers to "resist strongly" not to take Tylenol when unwell.

The US Food and Drug Administration then issued a notice that doctors should contemplate reducing the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism in children has remains unverified.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in spring to initiate "extensive scientific investigation" that would establish the cause of autism in a matter of months.

But authorities warned that finding a single cause of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a type of enduring cognitive variation and disability that affects how persons perceive and relate to the environment, and is identified using physician assessments.

In his legal document, the attorney general - who supports Trump who is seeking US Senate - claims Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the evidence" around acetaminophen and autism.

The case attempts to require the firms "eliminate any commercial messaging" that asserts Tylenol is safe for pregnant women.

The Texas lawsuit echoes the grievances of a collection of mothers and fathers of young ones with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.

A federal judge rejected the case, stating investigations from the parents' expert witnesses was lacking definitive proof.